Drug Therapy

  • 2017 Update in perioperative medicine: 6 questions answered
    Ryan Munyon, MD, Steven L. Cohn, MD, FACP, SFHM, Barbara Slawski, MD, MS, SFHM, Gerald W. Smetana, MD, MACP and Kurt Pfeifer, MD, FACP, SFHM
    Cleveland Clinic Journal of Medicine November 2017, 84 (11) 863-872; DOI: https://doi.org/10.3949/ccjm.84a.17068

    Topics: cardiac risk assessment, surgery after percutaneous intervention, statins, sleep apnea, bridging anticoagulation, and frailty.

  • ADHD: Overdiagnosed and overtreated, or misdiagnosed and mistreated?
    Michael J. Manos, PhD, Kimberly Giuliano, MD and Eric Geyer, BA
    Cleveland Clinic Journal of Medicine November 2017, 84 (11) 873-880; DOI: https://doi.org/10.3949/ccjm.84a.15051

    Combined behavioral and drug therapy is best.

  • Diabetes medications and cardiovascular outcome trials: Lessons learned
    Kershaw V. Patel, MD, Natalia De Albuquerque Rocha, MD and Darren K. McGuire, MD, MHSc
    Cleveland Clinic Journal of Medicine October 2017, 84 (10) 759-767; DOI: https://doi.org/10.3949/ccjm.84gr.17006

    Drugs of several classes have demonstrated cardiovascular safety; empaglifl ozin carries a cardiovascular indication.

  • Navigating the anticoagulant landscape in 2017
    James D. Douketis, MD, FRCP(C), FACP, FCCP
    Cleveland Clinic Journal of Medicine October 2017, 84 (10) 768-778; DOI: https://doi.org/10.3949/ccjm.84gr.17005

    What is the best strategy in acute venous thromboembolism? How should anticoagulation be managed before surgery?

  • Optimizing diabetes treatment in the presence of obesity
    Mary Angelynne Esquivel, MD and M. Cecilia Lansang, MD, MPH
    Cleveland Clinic Journal of Medicine July 2017, 84 (7 suppl 1) S22-S29; DOI: https://doi.org/10.3949/ccjm.84.s1.04
  • Diabetes and obesity: Managing dual epidemics
    M. Cecilia Lansang, MD, MPH
    Cleveland Clinic Journal of Medicine July 2017, 84 (7 suppl 1) S3; DOI: https://doi.org/10.3949/ccjm.84.s1.01
  • Antiobesity drugs in the management of type 2 diabetes: A shift in thinking?
    Bartolome Burguera, MD, PhD, Khawla F. Ali, MD and Juan P. Brito, MD
    Cleveland Clinic Journal of Medicine July 2017, 84 (7 suppl 1) S39-S46; DOI: https://doi.org/10.3949/ccjm.84.s1.05
  • Medical Treatment of Diabetes Mellitus
    Mario Skugor, MD
    Cleveland Clinic Journal of Medicine July 2017, 84 (7 suppl 1) S57-S61; DOI: https://doi.org/10.3949/ccjm.84.s1.07
  • What is the role of roflumilast in chronic obstructive pulmonary disease?
    Chris Lau, MD, Atul C. Mehta, MD and Umur Hatipoglu, MD
    Cleveland Clinic Journal of Medicine January 2017, 84 (1) 13-15; DOI: https://doi.org/10.3949/ccjm.84a.15150

    It has been shown to reduce acute exacerbations in patients with severe disease.

  • Severely frail elderly patients do not need lipid-lowering drugs
    Laurie Herzig Mallery, MD, FRCPC, MSM, Paige Moorhouse, MD, MPH, FRCPC, MSM, Pam McLean Veysey, BSc (Pharm), Michael Allen, MD, MSc and Isobel Fleming, BScPharm, ACPR
    Cleveland Clinic Journal of Medicine February 2017, 84 (2) 131-142; DOI: https://doi.org/10.3949/ccjm.84a.15114

    Statins have no role as primary prevention in this population, and a minor role as secondary prevention.

Pages